Background: Insulin resistance is a major factor in the development of metabolic syndrome and is associated with central obesity and glucose intolerance. Resveratrol, a polyphenol found in fruits, has been shown to improve metabolic conditions. Although it has been widely studied how resveratrol affects metabolism, little is known about how resveratrol regulates lipogenesis with insulin signaling in 3T3-L1 adipocytes.
INTRODUCTION
Obesity is a serious health problem associated with increasing risk of various diseases including type 2 diabetes, hypertension, and coronary heart disease [1] . The imbalance between energy intake and expenditure results in increased size and number of adipocytes, which is believed to contribute to various metabolic abnormalities [2] . Thus, it is important to understand the mechanism of adipocyte differentiation and lipid accumulation, as well as changes in insulin-responsiveness as obesity progresses.
The murine 3T3-L1 cell line is an established insulinresponsive adipocyte model for studying adipogenesis [2, 3] .
When 3T3-L1 preadipocytes are treated with hormonal stimuli, they undergo differentiation to acquire the mature phenotype of adipocytes [4] . During adipocyte differentiation, transcriptional factors such as CCAAT/enhancer-binding proteins (C/EBPs) and peroxisome proliferator-activated receptor γ (PPARγ) are involved in the sequential expression
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of adipocyte-specific proteins such as glucose transporter 4 (GLUT4), aP2/422, stearoyl-CoA desaturase-1 (SCD-1) and fatty acid synthase (FAS) [5] [6] [7] . The GLUT4 expressed in mature adipocytes enables a dramatic increase of insulinstimulated glucose uptake [8] . Adipogenic insulin signaling in adipocytes depends on several signaling molecules, including insulin receptor substrate (IRS)-1 and -2, phosphoinositide 3-kinase (PI3K), and Akt (or PKB) [9] [10] [11] [12] . The theory that the insulin signal cascade is critical to mediate adipogenesis has been supported by the fact that several knockout mice models including insulin receptor or Akt exhibited defective fat cell formation [13, 14] . This suggests that the insulin signaling pathway is important both for adipocyte differentiation and insulin sensitivity of mature adipocytes.
Resveratrol, a polyphenol found in fruits, is a phytoalexin found in Polygonum capsidatum. The richest sources of this compound are peanuts, grapes, and red wine [15] . Previous studies have shown that resveratrol has beneficial effects including anti-cancer, antioxidant, and cardioprotective properties, as well as the ability to protect cells from lipid accumulation [16] . However, little is known about how resveratrol regulates lipogenesis with insulin signaling in 3T3-L1
adipocytes. This study found that high-dose resveratrol inhibits the insulin signaling pathway with concomitant suppression of glucose uptake, which resulted in reduced lipid accumulation in 3T3-L1 cells.
MATERIALS AND METHODS
Cell culture
3T3-L1 preadipocytes were propagated and maintained in DMEM containing 10% calf serum. To induce differentiation, 2-day postconfluent 3T3-L1 preadipocytes (designated day 0) were fed DMEM containing 10% FBS, 1 μg/ml insulin (I), 1 μM dexamethasone (D), and 0.5 mM 3-isobutyl-methylxanthine (M) until day 2. Cells were then fed DMEM supplemented with 10% FBS and 1 μg/ml insulin for two days, after which they were fed every other day with DMEM containing 10% FBS.
Glucose uptake assay
On day 8 of differentiation, resveratrol (Sigma) was add- 
RESULTS
Resveratrol inhibited lipid accumulation in 3T3-L1 adipocytes
Upon hormonal stimuli, growth-arrested 3T3-L1 preadipocytes rapidly reenter the cell cycle and undergo two or more rounds of mitotic clonal expansion in 2 days of differentiation induction [5] . In this period, cells begin to express C/EBPβ, C/EBPδ, and other transcription factors to activate the gene expression of two pleotropic transcription factors, C/EBPα and PPARγ, which are responsible for the acquisition of mature phenotype of adipocytes [17] . We previously reported that resveratrol inhibits adipogenesis by modulating the amount of reactive oxygen species, which blocks the C/EBPβ activation process [18] . In order to investigate the effect of resveratrol in lipid accumulation of adipocytes, the differentiating 3T3-L1 cells were treated with resveratrol after two days of differentiation induction, which may exclude the effect of resveratrol on mitotic clonal expansion (Fig. 1A) . As a result, treatment of 50 μM 
Resveratrol suppressed glucose transport in 3T3-L1 adipocytes
It was well documented that insulin stimulates glucose uptake by GLUT4 translocation and lipogenesis [19, 20] . We The effector of the insulin-induced glucose transport in adipocyte is GLUT4 [21] . Next, an immunofluorescence assay was performed to determine whether resveratrol influences GLUT4 translocation. The control cells translocated GLUT4 to the plasma membrane in response to insulin (Fig.   2B ). In contrast, cells pretreated by resveratrol (100 μM)
did not show definite translocation of GLUT4, indicating that resveratrol can reduce glucose uptake and inhibit GLUT4 translocation, which may result in reduced lipid accumulation in 3T3-L1 adipocytes. These data suggest that high doses of resveratrol do not improve insulin sensitivity, but instead block insulin signaling and glucose uptake in 3T3-L1 adipocytes.
Resveratrol inhibits Akt and Akt downstream targets in 3T3-L1 adipocytes
It has been previously demonstrated that Akt signaling is linked to the translocation of GLUT4 to the plasma membrane, resulting in the stimulation of glucose uptake by insulin [22] , and leading to activation of mammalian target of rapamycin (mTOR). To determine the effect of resveratrol on insulin signaling, 3T3-L1 adipocytes were pre-treated with or without resveratrol in the short-term (3 h) or long-term (16 h) before insulin stimulation. As a result, a short-term treatment of resveratrol repressed insulin signaling by decreasing Akt phosphorylation and inhibiting the kinase activity of mTOR (Fig. 3A) . Long-term resveratrol treatment had a different effect on the phosphorylation of Akt (Fig. 3B) . Akt phosphorylation was gradually increased in a dose-dependent manner (1-50 μM), but then decreased at high doses (100 μM). The protein of SirT1 was not affected by resveratrol (Fig. 3A) . These results suggest that short-term high doses of resveratrol cause down-regulation of Akt and mTOR on insulin signaling and will not improve insulin sensitivity. The results also show that longterm treatment with low doses of resveratrol may help control metabolic syndrome.
DISCUSSION
Many reports have implicated the role of the insulin signaling pathway; including insulin receptors, IRS-1 and -2, PI3K and Akt; in insulin-induced adipogenesis and insulin-stimulated glucose uptake [9] [10] [11] [12] . Binding of insulin to its receptor triggers the phosphorylation of insulin receptor substrate (IRS) proteins. Tyrosine phosphorylated IRS proteins recruit and sequentially activate phosphoinositide 3 kinase (PI3K) and protein kinase B (PKB, also known as AKT) [23, 24] . Several knockout mice models including insulin receptor, Akt, and PI3K exhibit defective fat cell formation [13, 25] , probably by inhibiting insulin-like growth factor (IGF) signaling. Thus, it is important to carefully consider whether a certain chemical affects fat cell formation or lipid accumulation. There are a number of studies about the beneficial effects of resveratrol on metabolism, but it has also been previously reported that resveratrol inhibits insulin signaling, including MAPK and Akt activation [16, 26] and PI3K [27] . Although mild inhibition of insulin signaling is associated with increased life span [26] , it remains unclear why resveratrol has beneficial effects on metabolic diseases.
We previously reported that reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion [18] . Resveratrol acted as an anti-oxidant, inhibiting the gradual increase of reactive oxygen species which is essential for the C/EBPβ activation. This was shown to be a SIRT1-independent pathway, and was also observed with other anti-oxidants such as genistein, epigallocatechin 3-gallate, and N-acetyl cysteine. Thus, as an anti-oxidant, resveratrol affects mitotic clonal expansion and adipocyte differentiation. This study focused on the effect of resveratrol on the insulin signaling pathway and lipid accumulation, so treatment with resveratrol was carried out after mitotic clonal expansion. Particularly, the glucose uptake assay was performed with fully differentiated adipocytes (Fig. 2) . Because white adipose tissue is thought to be one of the major sites of metabolic derangements, the effect of resveratrol on glucose uptake in adipocytes was it is also possible that resveratrol affected adipocyte differentiation, which is not associated with insulin signaling.
Nevertheless, high doses of resveratrol are clearly associated with GLUT4 translocation issues in mature adipocytes.
Resveratrol treatment leads to activation of SIRT1 both in vivo and in vitro [16, 30] . There is some evidence that SIRT1 is involved in energy metabolism control and has a lipid-lowering effect through AMPK stimulation [25, 31, 32] .
The present study demonstrated that inhibition of Akt activation in parallel with a reduction in the translocation of GLUT4 with resveratrol suppresses lipogenesis in SIRT-independent pathway. Previous and current data demonstrated that in vitro high doses of resveratrol inhibited adipogenesis, glucose uptake, and insulin signaling. These results suggest that resveratrol has different features according to dose and time period, and additional research is necessary to determine whether or not resveratrol is beneficial to human health.
